A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Burden of disease measurement quantifies the health loss attributable to specific diseases, injuries, and risk factors in a population, using the disability-adjusted life-year (DALY) as the standard metric. One DALY represents one year of healthy life lost — either through premature death (Years of Life Lost, YLL) or through living with disability (Years Lived with Disability, YLD, weighted by severity). The Global Burden of Disease (GBD) Study, coordinated by the Institute for Health Metrics and Evaluation (IHME), estimates DALYs for every disease in every country, providing the empirical foundation for global health priority-setting. Burden of disease evidence reveals that the conditions causing the most death and disability are not always those receiving the most funding or political attention — leading to evidence-informed reallocation of health resources.
Health systems must allocate scarce resources among competing demands, but what data should drive these decisions? Death certificates tell you what people die from, but not what conditions make their lives miserable. Hospitalization data tell you what is treated, but not what goes untreated. Burden of disease measurement attempts to capture the full picture — both mortality and morbidity — in a single comparable metric.
The DALY has two components. Years of Life Lost (YLL) counts the years of life lost to premature death: each death is assigned a loss equal to the remaining life expectancy at the age of death, using a standard reference life table (currently based on the lowest observed mortality rates globally, approximately 86 years for both sexes). A child who dies at age 5 loses approximately 81 years; an adult who dies at 70 loses approximately 16 years. Years Lived with Disability (YLD) measures the impact of living with a condition: the number of prevalent cases multiplied by the disability weight (a number between 0 and 1 representing the severity of the condition, where 0 = perfect health and 1 = death-equivalent). A condition with prevalence of 1 million and a disability weight of 0.3 generates 300,000 YLD.
The Global Burden of Disease Study is the largest systematic effort to quantify health loss worldwide. Started by the World Bank in 1990 and now coordinated by IHME at the University of Washington, GBD estimates DALYs for over 350 diseases and injuries, 84 risk factors, and 204 countries and territories, updated annually. The results have profoundly influenced global health priorities by making visible conditions that death statistics undercount: mental health disorders (high prevalence, low mortality), musculoskeletal conditions (enormous disability burden in aging populations), and neonatal conditions (high YLL in LMICs).
Disability weights are elicited through population surveys that present pairs of health state descriptions (e.g., "a person who has moderate low back pain" versus "a person who is blind") and ask respondents which state they consider healthier. The pattern of responses, analyzed through statistical models, produces weights for hundreds of conditions. This process is inevitably imperfect — weights reflect the survey population's values, descriptions of conditions are simplified, and comorbidity effects are difficult to capture. Despite these limitations, the GBD framework provides the most comprehensive empirical basis for comparing health loss across conditions, populations, and time — information that is indispensable for rational health resource allocation.